Abstract : A total of 131 Pasteurella (P.) multocida strains were isolated from the lungs of 1,064 pigs with respiratory clinical signs nationwide during 2009-2010 and 2013-2014. The strains of P. multocida comprised 77.1% serotype A and 22.9% serotype D. Analysis of a recent P. multocida outbreak in Korean pigs showed that the isolation rate of serotype D decreased annually. The incidence of antimicrobial resistance, as measured using minimal inhibitory concentration values, has decreased recently. Overall, further studies to characterize P. multocida isolated from pigs in Korea are needed to prevent P. multocida infection in the Korean swine industry
Pasteurella (P.) multocida is a pathogen that causes respiratory symptoms such as cough, pneumonia, atopic rhinitis, and severe breathing in pigs, alone or in co-infection with other pathogens, such as Bordetella bronchiseptica, Mycoplasma hyopneumoniae, and Pseudorabies virus [2, 8] .
P. multocida isolates have been classified into five serogroups, A, B, D, E, and F, based on capsular polysaccharide. Both A and D are the major P. multocida serogroups detected in the respiratory tract of pigs worldwide. Serogroup A plays a more important role in the pathogenesis of pneumonia than serogroup D, while serogroup D produces several virulence factors (hsf-1 and nanB) and a dermonecrotic toxin. Therefore, infections with serogroup D can cause serious symptoms [6, 7, 10, 13, 15] .
To reduce economic loss in the swine industry, various Pasteurella vaccines and antimicrobial agents have been used in Korea [5, 11, 12, 14] . According to the Korea Animal Health Products Association, the use of antimicrobial agents in livestock decreased steadily beginning in July 2011, until it was finally banned in March 2013 to avoid the overuse of antimicrobial agents in livestock and maintain public health through better food safety management. Therefore, use of Pasteurella vaccines in the animal industry has increased steadily and the several vaccine types are available commercially: 1) killed P. multocida cells; 2) whole P. multocida cells; 3) formalin-inactivated toxoids produced from authentic P. multocida toxin; 4) recombinant subunit P. multocida toxin derivatives; and 5) DNA vaccines comprising a modified P. multocida toxin gene [1, 4, 9] .
The purpose of the present study was to isolate P. P. multocida was inoculated into BHI broth (BD Difco, USA), cultured for 18 h, and subjected to DNA extraction using the boiling method. The KMT1 gene of P. multocida was amplified using specific primers (forward, 5'-ATCCGC-TATTTACCCAGTGG-3'; and reverse, 5'-GCTGTAAACGAA CTCGCCAC-3') as described previously [11] . To distinguish capsular polysaccharide types, multiplex PCR was performed as described previously. The amplified fragments were of sizes 1044 bp (capA), 760 bp (capB), 657 bp (capD), 511 bp (capE), and 851 bp (capF) after resolution in a 1.5% agarose gel. Multiplex PCR was performed to detect the hsf-*Corresponding author Tel: +82-31-467-1783, Fax: +82-31-467-1797 E-mail: yangdk@korea.kr .
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Ki-Eun Lee, Hwan-Won Choi, Hyun-Ye Jo, Ha-Hyun Kim, Dong-Kun Yang 1, pfhA, hgbB, toxA, and nanB virulence genes, as described previously [3] .
Minimal inhibitory concentrations (MICs) were determined using the standard broth dilution methods described in the Clinical and Laboratory Standard Institute guidelines (M31-A3) for veterinary microorganisms. The antimicrobial agents tested were: ampicillin, penicillin, ceftiofur, danofloxacin, enrofloxacin, gentamicin, neomycin, spetinomycin, tiamulin, tilmicosin, tulathromycin, florfenicol, chlortetracycline, sulphadimethoxacine. Escherichia coli ATCC25922 was used as the control strain.
In total, 131 P. multocida isolates were obtained from 1,064 pigs with respiratory clinical signs. Table 1 ). The regional distribution of isolates was as follows: Gyeonggi (n = 13), Chungbuk (n = 2), Chungnam (n = 34), Jeonbuk (n = 7), Jeonnam (n = 4), Gyeongbuk (n = 54), Gyeongnam (n = 16), and Jeju (n = 1). The seasonal incidence of P. multocida ranged from 5% to 13% (January to March), 3% to 16% (from April to June), 5% to 8% (July to September), and 5% to 16% (October to December).
The P. multocida isolates comprised 77.10% serotype A (n = 101) and 22.90% serotype D (n = 30). Of the 38 strains isolated in 2009, 24 (63%) were serotype A and 14 (37%) were serotype D. Of the 31 strains isolated in 2010, 23 (74%) were serotype A and 8 (26%) were serotype D. Of the 47 strains isolated in 2013, 39 (83%) were serotype A and 8 (17%) were serotype D. However, all of the 15 strains (n = 15) isolated in 2014 were serotype A (Table 1) . Analysis of a recent P. multocida outbreak in pigs showed that the isolation rate of serotype D has decreased annually. According to the Korea Animal Health Products Association, the vaccine amount including P. multocia type D producing toxoid and toxiod has been increased. For this reason, it is estimated that type D was reduced.
The distribution of hsf-1, pfhA, hgbB, toxA, and nanB virulence genes among P. multocida isolates was presented in Table 2 . The hsf-1 (autotransporter adhesion) and hgbB We concluded that the annual rate of detection of P. multocida serotype D has decreased recently and that the antimicrobial resistance rate of P. multocida isolates has decreased annually. The aim of the present study is a common characteristic study of the porcine P. multocida in Korea. The results can be provided as the basis data of current vaccines and antimicrobial agents to porcine respiratory disease and also, ongoing monitoring of P. multocida antimicrobial agents to porcine respiratory disease in Korea.
